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INTRODUCTION
Oocyte retrieval with transvaginal ultrasound guided fol-
licular puncture techniques are the routine in many in vitro
fertilization (IVF) centers, usually performed as a day-case
procedure under some form of analgesia or anesthesia (1). Infer-
tility has been characterized as creating a form of chronic stress,
and IVF is a very stressful experience especially for women (2).
In our clinical experiences, larger doses of narcotics or seda-
tives seemed to be administered to establish and maintain a
clinically sufficient hypnotic component of the anesthetic state
in anxious females receiving oocyte retrieval, especially those
who had experienced the same procedures repeatedly before.
Although several studies have investigated the influence of
preoperative anxiety upon intra-operative anesthetic require-
ment (3, 4) and postoperative recovery profiles (5-7), there
are some curiosity left about the conscious sedation require-
ment and the contributing factors in the highly anxious infer-
tility patients.
The present research project sought to address the follow-
ing questions: 1) Does preoperative anxiety level relate to the
number of IVF cycle? 2) Is increased anxiety associated with
increased sedation requirement for induction and maintenance?
and 3) Do the psychological or the physiological preoperative
factors predict higher propofol requirement for ovum retrieval
under target-controlled conscious sedation?
MATERIALS AND METHODS
The study was carried out on a sample of 126 Korean wo-
men (ASA 1) who had been accessed consecutively on the
oocyte retrieval during the period of March to May 2001 at
the Infertility Center. The Institutional Review Board ap-
proved it, and informed consent was obtained from all patients.
Patients with a history of psychiatric illness or patients taking
psychotropic medications were excluded. None of the patients
had ever had children or lived with a child from the husband’s
previous relationship.
On the day of surgery, demographic data including age, the
trial number of IVF cycle (cycle), the time elapsed since diag-
nosis (duration), and the type of infertility diagnosis (diagno-
sis) were obtained from the patients’ charts by an anesthesiol-
ogist who was not involved in sedation. The clinical back-
grounds of the subjects are presented in Table 1. No sedative
premedication was offered to any of the patients.
Psychological Measures
Next, psychological measures were evaluated at the isolated
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Preoperative Anxiety and Propofol Requirement in Conscious
Sedation for Ovum Retrieval 
The purpose of the present study was to evaluate the correlation among the trial
number of in vitro fertilization (IVF), preoperative anxiety, and propofol requirement
for conscious sedation. One hundred and twenty six Korean women undergoing
oocyte retrieval were enrolled. The target-controlled infusion by the anesthesiol-
ogist was conducted with initial target propofol concentration of 2.5  g/mL, which
was manipulated until the sedation score 3 and desired clinical end point were
achieved. A weak correlation was observed between visual analogue scale (VAS)
anxiety and the dose of propofol required for the induction of conscious sedation
(r=0.22, p=0.0192). A weak correlation was also found between VAS anxiety and
the sedation time needed to reach the proper conscious sedation level for the pro-
cedure (r=0.181, p=0.0484). Multiple regression analysis showed that VAS anxi-
ety, preoperative baseline prolactin level, and cortisol level had statistically signifi-
cant effects on the propofol induction dose for target controlled conscious sedation.
We concluded that the induction dose and time requirements for propofol in anes-
thesiologist-controlled conscious sedation be modified based on the preoperative
anxiety level and the baseline blood concentration of stress hormone, cortisol and
prolactin.
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preparing room. Trait and state anxiety were assessed using
the State-Trait Anxiety Inventory (STAI) of Spielberger (8).
The STAI is a widely used self-report anxiety assessment in-
strument. The STAI-State subscale is designed to measure
transitory anxiety states, that is, subjective feelings of appre-
hension, tension, and worry that vary in intensity and fluctu-
ate based on the situation. The STAI-Trait subscale measures
relatively stable individual differences in anxiety proneness,
that is, differences in the tendency to experience anxiety. The
reliability coefficient (Cronbach’s Alpha), referring to the Kore-
an adult female normative sample, is 0.91 for state and 0.82
for trait (9).
The visual analogue scale (VAS) for subjective feeling of
anxiety was measured, which consists of a 10 cm line anchored
at one end by a label such as ‘‘not anxious’’ and at the other
end by a label such as ‘‘anxious as can be’’.
Physiological Measures
Cortisol and prolactin are known to be sensitive indicators
to stress because they may play roles as the mediators of psy-
chological stress. Blood samples were taken for the assay of
prolactin and cortisol concentrations at the early follicular
phase of the treatment cycle (day 3) and in the morning of
the day of oocyte retrieval shortly before the anesthetic induc-
tion. All blood samples were collected between 0830 and
1200 hr. The corresponding blood samples were centrifuged
immediately, and the serum was stored at -20℃until required
for assay.
Serum cortisol was assayed using the kits for solid-phase
radioimmunoassay of Diagnostic Products Corporation (Los
Angeles, CA, U.S.A.). The intraassay and interassay precision,
expressed as the coefficient of variation of two pools of serum,
were 4.8% and 5.2%. Serum prolactin was measured using
immunoradiometric assay (Daiichi, Tokyo, Japan), intraassay
and interassay precision of the two serum pools were 2.6%
and 3.6%, respectively.
Target-Controlled Conscious Sedation by an Anes-
thesiologist
After obtaining the baseline recording of electrocardiogram,
heart rate, noninvasive arterial blood pressure, and SpO2, a
standardized sedation regimen was initiated. The Target-Con-
trolled Infusion (TCI) system runs on a microcomputer con-
nected to an infusion pump (Becton-Dickinson infusion sys-
tem, Le Grande Chemin, France). An infusion of propofol with
a preset target concentration of 2.5  g/mL was started until
the patient had reached and maintained sedation level 3 on
a 5-point sedation scales (Table 2). Cooperation and treatability
were additional end points. If these clinical end points were
not reached within 3 min (inadequate sedation), the target
concentration was increased in steps of 0.2  g/mL until treat-
ment could be performed. Once sedation score 3 was reached,
the propofol target level was maintained unless signs of overse-
dation became apparent (sedation score 4), as indicated by
diminished communication or decreasing SpO2. In that event,
the target concentration was decreased in steps of 0.2  g/mL
and the procedure was temporarily halted until the desired
sedation level was achieved. Similarly, when a noninhibitory
type of oversedation was present (agitation, excitement, rest-
lessness, and lack of cooperation), the target concentration was
decreased in the same way. The targeted propofol concentra-
tions were based on clinical trials in the patient population.
Routine oxygen was administered. Positive pressure ventilation
was available as required in the event of hypoxemias (SpO2<
90%). No opioids were administered.
Induction time of sedation (time consumed to sedation level
3), sedation dose (dose required to sedation score 3) and total
intraoperative dose of propofol, target-concentration, calculat-
ed-concentration, and effective site-concentration of propofol
on the TCI-system at sedation score 3 achieved were recorded.
Statistical Analysis
The main associations we examined were the number of
IVF-cycle versus the level of preoperative anxiety, and the
level of anxiety versus the amount of propofol required for
the induction and maintenance of conscious sedation. Data
were analyzed with the use of SPSS version 10.0 (SPSS Inc.,
Chicago, IL, U.S.A.).
The sample was divided into three subgroups according
to the cycle: (i) women who were undergoing their first IVF
Values are mean±SD.
Cycle: the trial number of IVF cycle, Duration: the time elapsed since
diagnosis, Diagnosis: the type of infertility diagnosis.
Age (yr) 33.8±4.8
Weight (kg) 54.8±8.0
Height (cm) 159.5±4.8
Cycle 4±3.2 (range 1-22)
Duration (month) 59.3±40.9 (range 2-156)
Diagnosis (%)
Male alone 24.6
Female alone 45.6
Both 21.9
Unknown 7.9
Job position (%)
Housewife 69.0
Employed 31.0
Table 1. Clinical background of subjects (n=126)
Sedation Score
1 Fully awake and oriented
2 Drowsy
3 Eyes closed, responds promptly to verbal commands
4 Eyes closed, aroused on mild physical stimulation only
5 Eyes closed, not aroused on mild physical stimulation
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cycle, (ii) women who were undergoing their second or third
attempt, and (iii) women who were in their fourth or more
attempt. In order to evaluate the association between the num-
ber of IVF cycle and psychological, hormonal, physiological
anxiety parameters, or others, we referred to the analysis of
variance (ANOVA). For a more detailed analysis of the phe-
nomena, we considered diagnosis and duration. For diagno-
sis, there were four subgroups: (i) male factor, (ii) female fac-
tor, (iii) both of the couple, and (iv) unknown factor. Referring
to the median of infertility duration, we classified the subjects
into two subgroups, those suffering for less than 54 months
(short-term group), and those more than 54 months (long-
term group). We used unpaired t-test for the comparison.
The associations of preoperative anxiety to propofol require-
ments for conscious sedation and serum concentration of pro-
pofol on TCI system were evaluated by Spearman’s correlation
analysis.
Finally, a stepwise linear regression analysis was used to
determine which of the variables could predict the sedation
requirement of propofol. All regression models were performed
using the SPSS computer program. Comparisons were con-
sidered significant if p<0.05.
RESULTS
One hundred and twenty six patients were enrolled in this
study. The patients were 26-46 yr old (34±4, mean±SD).
The mean duration of infertility was 59.3±40.9 months, the
median was 53.5 months. Preoperative state-anxiety of all
patients, as assessed by STAI was 40.0±9.7, and the trait-
anxiety was 42.6±7.9. Self-report anxiety expressed by VAS
was 4.7±2.3. The average propofol induction dose required
for the sedation was 1.2±0.4 mg/kg. An average of 0.23±
0.05 mg/kg/min total propofol was required intraoperatively.
The mean propofol infusion time was 13.1±2.5 min, and the
mean sedation time to reach sedation score 3 from the start
of propofol was 2.2±0.8 min.
In the subgroups of the cycle variables, there were no sig-
nificant differences in the state, trait-anxiety score, VAS of
anxiety score, and serum prolactin and cortisol level (Table 3).
In the subgroup of the duration variable, no significant dif-
ference was found in the anxiety values or in the hormonal
levels (Table 4). Among the anxiety values and the hormonal
levels, there was no significant difference in the comparison
made among the diagnosis of infertility (p>0.05).
As expected, the patient’s state and trait anxieties correlat-
ed significantly with each other (r=0.45, p=0.000). We found
that increased preoperative state anxiety did not correlate sig-
Short-term Long-term  p
Group Group
Anxiety Scores
STAI-State 44.2±7.3 44.0±8.1 0.662
STAI-Trait 40.7±7.1 38.8±6.6 0.725
VAS
Stress Hormone ( g/mL)
Prolactin-OPD 8.45±4.6 7.66±3.4 0.054
Prolactin-OR 8.74±3.5 9.00±3.9 0.719
Cortisol-OPD 24.3±13.7 25.0±13.5 0.946
Cortisol-OR 13.4±4.3 13.2±5.6 0.118
Induction Quality
Sed-Dose (mg/kg) 1.24±0.4 1.18±0.4 0.478
Total-Dose 0.24±5.8 0.23±5.3 0.437
(mg/kg/min)
Sed-Time (sec) 131.3±84.9 132.5±81.4 0.633
Table 4. Anxiety scores and stress hormones for the duration
subgroups
Cycle I
(n=57)
Cycle II
(n=39)
Cycle III
(n=30)
p
Anxiety Scores
STAI-State 44.6±7.2 43.8±8.4 43.7±7.9 0.626
STAI-Trait 39.4±6.3 40.0±7.6 40.4±7.4 0.302
VAS 4.1±2.0 3.4±2.3 3.4±2.1 0.593
Stress Hormone ( g/mL)
Prolactin-OPD 9.6±4.0 7.8±3.5 8.0±4.0 0.079
Prolactin-OR 9.2±3.4 8.3±4.6 8.8±2.4 0.670
Cortisol-OPD 27.4±14.0 22.0±12.5 21.7±13.3 0.080
Cortisol-OR 13.2±4.6 12.9± 6.0 14.0±4.0 0.684
Induction Quality
Sed-Dose (mg/kg) 1.23±0.4 1.15±0.4 1.22±0.4 0.651
Total-Dose 0.24±5.9 0.23±5.2 0.23±5.1 0.696
(mg/kg/min)
Sed-Time (sec) 137.2±86.6 124.8±81.5 126.4±77.4 0.732
Table 3. Anxiety scores, stress hormones, and induction quality
for the cycle subgroups
Values are mean±SD.
Cycle I: women who were undergoing their first trial of IVF cycle, Cycle
II: women who were undergoing their second or third attempt and Cycle
III: women who were in their fourth or more attempt. Prolactin-OPD: blood
prolactin concentrations at the early follicular phase of the treatment cycle
(day 3), Prolactin-OR: blood prolactin concentrations in the morning of
the day of oocyte retrieval shortly before the anesthetic induction, Corti-
sol-OPD: blood cortisol concentrations at the early follicular phase of the
treatment cycle (day 3), Cortisol-OR: blood prolactin concentrations in
the morning of the day of oocyte retrieval shortly before the anesthetic
induction. Sed-Dose: propofol dose required for induction of sedation,
Total-Dose: total propofol dose for the procedure, Sed-Time: induction
time reached to sedation score 3 from start of propofol. There were no
significant differences in all variables.
Values are mean±SD.
Short-term group: those suffering for less than 54 months, Long-term
group: those more than 54 months. Prolactin-OPD: blood prolactin con-
centrations at the early follicular phase of the treatment cycle (day 3),
Prolactin-OR: blood prolactin concentrations in the morning of the day
of oocyte retrieval shortly before the anesthetic induction, Cortisol-OPD:
blood cortisol concentrations at the early follicular phase of the treatment
cycle (day 3), Cortisol-OR: blood prolactin concentrations in the morn-
ing of the day of oocyte retrieval shortly before the anesthetic induction.
Sed-Dose: propofol dose required for induction of sedation, Total-Dose:
total propofol dose for the procedure, Sed-Time: induction time reached
to sedation score 3 from start of propofol.866 J.-Y. Hong, I.S. Kang, M.K. Koong, et al.
nificantly with the propofol required for the induction of
conscious sedation, nor was the total intraoperative propofol
infusion dose required for maintenance. Trait anxiety did not
correlate with the propofol for the induction, nor for the main-
tenance. However, a weak correlation was observed between
VAS anxiety and the propofol dose required for the induction
of conscious sedation, but not between VAS anxiety and total
dose of propofol. In addition, a correlation was found between
VAS anxiety and the sedation time, which means the time
from the start of propofol infusion to the time proper seda-
tion level was reach for the procedure (Fig. 1).
Statistically significant correlations were found in preop-
erative serum cortisol level and two STAI scores (Table 5).
Prolactin levels just before the procedure had significantly
negative correlation with STAI-state only. Interestingly, there
were no significant correlations between VAS anxiety score
and these two stress hormones.
We found that preoperative VAS anxiety, state anxiety,
and trait anxiety were not correlated with the target concen-
tration, calculated concentration, nor effective site concentra-
tion of propofol on TCI system for conscious sedation.
To evaluate the unique contribution of each variable to the
prediction of intraoperative sedation requirements, two step-
wise multiple regression models were constructed. In the first,
the propofol required for induction was the dependent vari-
able, and the independent variables included state-anxiety,
trait-anxiety, VAS anxiety, cycle, and prolactin and cortisol
concentration. In the second model, total propofol dose for
the procedure was a dependent variable. Multiple regression
analysis showed that VAS anxiety (F=5.644, p=0.019), pre-
operative baseline prolactin level (F=4.611, p=0.035), and
preoperative baseline cortisol level (F=7.308, p=0.008) had
*: p<0.05.
STAI-State r 0.099 0.221 -0.117 -0.194
p 0.422 0.016* 0.347 0.035*
STAI-Trait r -0.024 0.203 -0.145 -0.072
p 0.844 0.027* 0.241 0.435
VAS r 0.113 0.033 -0.019 0.063
p 0.365 0.724 0.877 0.497
Table 5. Correlation between the anxiety scores and the stress
hormones
Prolactin
OPD OR
Cortisol
OPD OR
Fig. 1. A weak correlation is observed between VAS anxiety and
the propofol dose required for the induction of conscious sedation
(sedation score 3), but not between VAS anxiety and total dose
of propofol. A weak correlation is also found between VAS anxi-
ety and the sedation time, which means the time from the start
of propofol infusion to the time proper sedation level was reached
for the procedure.
*: p<0.05.
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p=0.048*significant effects on the propofol induction dose for conscious
sedation. So, the patients with increased VAS anxiety scores,
with elevated preoperative concentrations of prolactin and
cortisol could require more anesthetics for conscious sedation.
DISCUSSION
Our main goals were to assess the relationship among the
trial number of IVF cycle, preoperative anxiety, and intraoper-
ative sedation requirement of propofol. We found that there
were no significant psychological measurements, hormonal
values, and sedation dose between women who underwent
their first cycle and women who underwent a repeated cycles.
Though there is a difference in opinion (10), we shared the
views of some authors. The cross-sectional study of Beaurepaire
and colleagues (11) showed that both men and women expe-
rience anxiety during an IVF treatment, independent of the
number of cycles. Reading et al. studied psychological reactions
in 37 women over the course of IVF, and found that there were
no significant differences between women with first time or
repeated cycles (12). However, concerning mood, scores on
anger and confusion increased significantly over time. In an
exploratory survey of an Italian sample, the number of IVF
cycles did not appear to match significantly with the anxiety
state (13). Among the other variables such as diagnosis, dura-
tion of infertility and pregnancy outcome, significant differ-
ences were noted. In their sample, a longer duration of infer-
tility, rather than the repetition of the cycles, may help in cop-
ing with oocyte retrieval with less tension. These results do
not agree with Berg and Wilson’s finding (14) and ours. We
believe that this is due to the different criterion used in subdi-
viding the sample in our study and theirs. Although we could
not find the effect of infertility duration on the anxiety scores,
unusual persistence with which women cling desperately to
treatment despite the length tend to bring about ‘‘chronic feel-
ings of unhappiness’’. Chiba and co-workers suggested that the
psychological symptoms of infertile women seem to be close
to the level of neurosis, and long-term infertility might aggra-
vate their neurotic tendency rather than anxiety itself (15).
With regard to the sedation requirement, we could not
observe any correlation between STAI considered ‘‘Gold Stan-
dard to assess anxiety’’ and sedation requirement of propofol.
In contrast, interestingly, a weak but significant correlation
was observed between VAS anxiety and the propofol dose
required for the induction of conscious sedation. In addition,
a weak correlation was also found between VAS anxiety and
sedation time. It is assumed from clinical experience includ-
ing ours that larger doses of anesthetics are required in the
anxious patients to induce and maintain a clinically sufficient
sedation for various procedures. Previous studies published
in the psychological and anesthesia literatures have yielded
contradictory findings. Parris and others suggested that in-
creased anxiety before surgery is associated with increased
intraoperative anesthetic requirements (16). Williams et al.
reported highly anxious patients require a greater amount of
sodium thiopental to induce anesthesia than less anxious pa-
tients (17). Goldman et al. assessed state anxiety in 53 women
presented for gynecological surgery who underwent general
anesthesia (3). The investigators reported that preoperative
anxiety seems to correlate with the amount of methohexitone
required, but this relationship was not statistically significant.
Maranets and Kain demonstrated that there was a moderate
correlation between trait anxiety level and the amount of
propofol required for the induction and maintenance of anes-
thesia (4). They found that situational (STAI-state) anxiety
immediately before surgery was not associated with intraop-
erative anesthetic requirements. In contrast, high baseline
(STAI-trait) anxiety did predict increased intraoperative anes-
thetic requirements. Our assessment of both STAI did not
appear to correlate with the amount of propofol required for
induction or maintenance. Meanwhile, we found that the VAS
anxiety score with which the patients self-expressed their own
anxiety had a significant correlation to the sedation require-
ments and time requirements for the induction with propo-
fol. According to our interesting result, however, we do not
know exactly why, we could suggest that preoperative VAS
anxiety self-recorded score predict the dose and time require-
ments for conscious sedation with propofol. The best-known
tool for anxiety evaluation is Spielberger’s STAI, which was
referred to recently in a major anesthesia journal as the ‘‘gold
standard’’ for measuring preoperative anxiety (18). So, the
discrepancies to the previous reports may in part be explained
by the fact that the patients took the procedure under different
conditions in general anesthesia or conscious sedation. Careful
interpretation of the results may be needed. Generally ‘‘general
anesthesia’’ is suggested to consist of unconsciousness, lack of
recall, analgesia, and muscle relaxation. The words used to
describe ‘sedation’ have been confused to ‘calmness’, ‘anxiol-
ysis’, ‘somnolence’, ‘drowsiness’, or ‘sense of well-being’. The
aim of conscious sedation in this specific group of patients is
to alleviate anxiety, thus enabling anxious patients to accept
treatment and to experience no more than minimal discom-
fort, and easing technically difficult procedures for the oper-
ator. This may reflect the fact that the quality of sedation tends
to depend on the subjective feeling of anxiolysis, and the qual-
ity of general anesthesia depends on the anesthetic components.
It is unclear how and which factors control the patient’s anxiety.
There are complicating factors including the type of operation,
patient’s subgroup, individual patients characteristics such as
personality dimension, self-esteem, marital satisfaction, reli-
gion, motivation, compliance, locus of control, and reaction
to pain. However, it is equally unclear how these allow patients
to cope with their procedure and control the anxiety under
light sedation. It may be interesting in future studies and more
careful approach may be needed.
Although we used validated measures to assess anxiety, our
anesthetic technique consisted of only one variable, and we
Preoperative Anxiety and Conscious Sedation Requirement 867also controlled the surgical procedure and the patients, the
important limitation concerning the design of our study was
addressed. We responded to changes just in sedation level by
changing the target-concentration of propofol. In addition,
the sedation scale we used could not accurately determine the
subtle change in the level of sedation, and sedation might be
interrupted by the check. Measuring and monitoring of the
hypnotic component like a bispectral analysis would have
been more helpful for the present study. 
In conclusion, we demonstrated that there are significant
correlations between preoperative VAS anxiety and the amount
of propofol and the consuming time required for the induc-
tion of conscious sedation in this study. Among the anxiety
values and the hormonal levels, there was no significant dif-
ference in the comparison made among the trial number of
cycle, duration of infertility, or diagnosis of infertility. There-
fore, we suggest that the induction dose and time of propofol
for anesthesiologist-controlled conscious sedation should be
modified based on the preoperative anxiety level exhibited by
each patient.
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